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Several methods of enumerating Enterococci in water are suggested in the literature, notably 
membrane filtration and mEA plating. To establish  optimal growth conditions, including incubation time,  
(24 and 48 hr) and  temperature  (35°C and 41°C), samples of 0.1 mL, 1 mL and 10 mL  filtered water 
collected from Lake Artemisia, MD, USA  were amended with known concentrations of Enterococcus 
faecalis (ATCC 29212), filtered using  0.45 µm membrane filters, and incubated on mEA agar under 
different conditions: 35°C/24h, 35°C/48h, and 41°C/48h, following  U. S. Environmental Protection 
Agency guidelines. Results demonstrated no significant difference among the volume and time of 
incubations used but a significant difference in the temperatures employed.  
Being the etiological agent of cholera, V. cholerae is a major public health problem in several 
developing countries. The prevalence of β-lactamase-producing strains and their isolation from life-
threatening infections as well as the environment is alarming and presents a major therapeutic challenge 
for clinicians. The extended-spectrum β-lactamase profile of a collection of 210 V. cholerae O1 strains 
isolated from clinical and water samples was investigated. The strains were collected during ongoing 
 
 
epidemiological and ecological cholera surveillance in the provinces of Chhatak and Mathbaria in 
Bangladesh, between March 2009 and April 2012. Resistance to penicillins, monobactams, carbapenems, 
second-, third- and fourth- generation cephalosporins were tested by disk diffusion. Genotypic analysis of 
the resistance determinants was performed by PCR to detect ESBL (blaCTX, blaTEM, blaSHV), 
carbapenemases (blaIMP, blaSPM, blaVIM, blaBIC, blaNDM, blaKPC, blaAIM, blaSIM, blaDIM, and 
blaGIM). All strains were sensitive to the 4th–generation beta-lactam cefepime. This is the first 
report documenting such extensive resistance to monobactams and third-generation 
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1.1 Background on ballast water 
Ballast water is used to add weight and keep the balance of ships and cargo. It is the 
additional weight that is essential to bringing the vessel to a suitable draft and trim in order to 
decrease stresses and enhance stability [1]. Ships that are empty of cargo fill their tanks with 
ballast water that is later discharged when they reach their destination or are loaded with cargo. 
This water contains a wide variety of organisms that can be transported nationally and 
internationally [2]. Organisms present in ballast water can be introduced to new marine 
environments, where they may establish themselves and alter or impact the receiving 
ecosystems. This may pose a threat to the local marine ecological system since the community of 
organisms present may contain pathogens, including those affecting humans that are common in 
coastal waters [3, 4].  
Aquatic species are introduced into new environments both through natural evolutionary 
processes such as wind or ocean currents, and through human activity. One way for foreign 
species to be introduced into new habitats is by transport vectors that transfer them well beyond 
their natural range. The first reported incident of a non-native species causing a problem was in 
1903, when an Asian alga, Odontella sinensis, overgrew and caused a massive population 
explosion in the North Sea. Another example of a ballast water related incident was in 1991 and 
1992, when Vibrio cholerae strain O1 was detected in ballast, bilge and sewage water of five 
cargo ships docked in ports on the U.S. Gulf Coast [5]. 
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The International Maritime Organization (IMO) divides the impact of invasion by 
microorganisms on the environment into three different categories. Ecological impacts are the 
first category when invasive organisms change and sometimes disrupt the biodiversity and 
ecological processes in an aquatic ecosystem. The second category consists of economical 
impacts, when different industries and commercial activities and resources are disrupted by the 
invading species. The third category of impact includes public health concerns that arise as 
pathogens and toxic organisms can cause diseases [4]. 
Concerns about the spread of potentially pathogenic bacteria via ballast water began when 
shellfish associated Vibrio cholerae was detected in water in ballast tanks of several ships that 
had come from South America. Water that contained these microorganisms was saline, 
indicating that these microorganisms are capable of surviving harsh conditions such as high 
salinity and pH [6]. The biology of many microorganisms may enable invasion, a high capacity 
for increase, asexual reproduction, and the ability to form dormant resting stages. Many of these 
pathogenic microorganisms are also capable of tolerating a broad range of environmental 
conditions, such as in salinity or temperature [4]. 
1.2 Microbiological concerns of ballast water 
Essentially, invasive species and the transfer of aquatic microorganisms, including viruses, 
bacteria, protists, and microalgae in aquatic environment are investigated for the following 
reasons: their high densities in the aquatic environment, ability to form resting stages, and 
potential toxicity or pathogenicity. Aquatic microorganisms have a higher abundance than 
macro-organisms such as copepods. Since the density of microorganisms is higher than that of 
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any other size class of organisms, they get transferred and introduced globally via ships ballast 
water at a greater rate [7, 8]. 
Microorganism’s small size facilitates their passive dispersal. In addition, their relatively 
high survival rates due to their ubiquity in the biosphere, their asexual modes of reproduction and 
their ability to form resting stages contribute to their widespread distribution and ability to 
survive prolonged periods of unfavorable conditions [9]. 
While the vast majority of microorganisms occur naturally and are not harmful to humans, 
ballast water may contain both varieties of harmful microorganisms, indicator organisms and 
pathogens that represent risks to public health. These pathogenic microorganisms such as Vibrio 
cholerae are present in low levels which makes their detection difficult. Furthermore, the 
presence of harmful microorganisms and indicator bacteria such as Enterococci and E. coli in 
ballast tanks and residuals may help pathogens spread undetected into fresh and marine waters 
[10]. 
1.3 Why certain bacteria have been used for studying ballast water 
It is challenging to detect and inactivate live and dead microorganisms, particularly the 
smaller microorganisms like bacteria and viruses. Since bacteria have a high reproduction 
potential and are ubiquitous in the natural environment (they have the ability to withstand 
extreme environmental conditions), monitoring their inactivation is complex. Moreover, our 
information on bacterial diversity in water is very limited and detection of small microorganisms 
in the aquatic environment is a challenging concept [11]. The ballast water standards, therefore, 
give special emphasis to the challenges in detection and inactivation of organisms <10 μm and, 
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therefore, the basis of this is placed on these indicator microbes mostly associated with fecal 
contamination. 
According to IMO procedures (IMO 2004), three bacterial species have to be tested for 
ballast water quality and bacterial contamination: E. coli, Enterococci, and V. cholerae. These 
three microorganisms will be further described in the next paragraphs [12]. 
1.3.1 E. coli and Enterococci 
Viability and culturability of pathogens that enter the aquatic environment through run 
offs, the presence of wildlife and their utilization of watersheds may vary outside of the host. 
This presents a problem when attempting to predict the overall public health safety of the aquatic 
environment, with respect to pathogenic microorganisms [13]. To address this problem, suites of 
bacteria of fecal-origin, called fecal indicator coliforms, are used as proxies for the presence of 
enteric pathogens of human and animal origin. 
These indicator organisms are residents of human in the gastrointestinal tracts as well as 
animals. They are used throughout the world to assess the microbiological safety of drinking 
water, recreational waters, and ballast water [14]. Fecal indicators are used more specifically to 
assay fecal contamination in environmental samples. They are gram negative, rod shaped, 
facultative anaerobic bacteria that have the ability to remain in the environment with unfavorable 
conditions without rapidly growing. They can be used as the source identifier in microbial 
methods designed for determining the source(s) of fecal pollution [14]. 
Fecal pollution of ballast water is related to land-based discharges, coastal diffuse sources 
and liquid wastes that are released from other ships. This fecal contamination represents a 
potential health risk to the aquatic environment and to humans if released in coastal areas [10]. E. 
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coli and Enterococci are used in measuring the presence of pathogenic organisms in ballast 
water. These two organisms are believed to provide a higher correlation than other fecal 
indicators with many of the human pathogens often found in ballast water [4, 9, 15]. 
In 1976 the USEPA and the European Community Bathing Water Directive called for the 
use of coliforms as indicators of water quality; however it has been demonstrated that 
environmental samples contain a large fraction of these bacteria that are not of fecal origin, such 
as Klebsiella and Citrobacter[16], thus making their use as indicators of water quality 
questionable.  Epidemiological studies later demonstrated that the numbers of enterococci and 
Escherichia coli bacteria in samples collected at several freshwater and coastal beaches were 
directly related to cases of gastroenteritis in the aquatic environment. Based on the results of 
these studies the USEPA adopted the use of enterococci and Escherichia coli as proxies for 
estimating public health safety of recreational water.  Escherichia coli has been suggested to be a 





inability to replicate outside the host under certain environmental conditions, while persisting at 
least the same length of time as other fecal pathogens discharged into aquatic environments.   
Enterococci are considered to be reliable indicators of fecal pollution because of their limited 
host range (humans, dogs, and chickens)[17]. Assessing environmental water quality can be 
more beneficial if focus is given to a group of Enterococcus sp. that is associated with fecal 
contamination sources and therefore, E. faecalis and E. faecium are predominantly used. US 
Environmental Protection Agency (US EPA) in 1986 recommended the use of Enterococci as an 
indicator organisms in the aquatic environment based on a series of epidemiological studies 
performed on recreational waters that demonstrated that the concentration of Enterococci 
correlated best with bather illness[18]. 
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Enterococci are Gram-positive cocci, non-sporeforming, catalase-negative bacteria that 
occur in pairs or short chains. They are important members of gut communities in many animals 
and opportunistic pathogens that cause millions of infections annually. Enterococci are 
facultative anaerobic but prefer anaerobic conditions and have the ability to tolerate a variety of 
harsh conditions such as high temperatures, pH and salinity. They don’t naturally occur in 
environmental waters and therefore their presence in this environment is tied to fecal pollution. 
Among the most commonly found species of this bacteria in environmental waters are E. faecalis 
and E. faecium[19]. One of the first scientists to suggest the use of Enterococci as fecal indicator 
bacteria were Ostrolenk et al.[20] and studies performed during the 1970s and 1980s confirmed 
this suggestion for marine waters. More recent studies performed on recreational waters, have 
also confirmed the previous studies by demonstrating a correlation between elevated 
concentrations of Enterococci and the risks of humans contracting gastroenteritis mostly when 
point source contamination is present[21]. Since Enterococci are not virulent, simple and rapid 
methods for their detection and enumeration exist, and their presence is strongly associated with 
the presence of pathogens while they have survival characteristics similar to those of pathogens 
in external environments, they are ideal for use as fecal indicator bacteria. 
1.3.2 Vibrio cholerae 
Vibrio cholerae is the agent of cholera in humans. This highly pathogenic, gram negative 
and highly ubiquitous bacterium is a great risk to humans since after host infection, it causes 
severe dehydration that can lead to death in most severe cases. V. cholerae secretes cholera toxin, 
a protein that causes profuse, watery diarrhea and is carried by the ctx gene. [9] 
Most environmental isolates of V. cholerae lack the virulence factors that are present in 
clinical isolates. However, different studies have demonstrated that they have the ability to 
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acquire serological determinants and toxin genes through horizontal gene transfer, the process by 
which prokaryotes exchange genetic material [22]. 
Vibrio cholerae is a useful indicator for the presence of pathogens and significance 
transmission of pathogens via ballast water. Since this bacterium is present in many aquatic 
environments, it can easily get transferred to different ports in ballast water while still remaining 
viable. Even though it is difficult to detect and estimate the concentration of viable cells, the 
transmission of V. cholerae by ships gives them an opportunity to colonize coastal ecosystems. 
V. cholerae is a common habitant of the aquatic environment, where it persists without human 
contact. Hence, if a new strain with a novel genotype evolves and gets taken up in ballast tanks, 
local conditions may favor its establishment [4]. 
Special attention was given to the transport of bacteria via ballast water after the number 
of data illustrating transport of pathogenic bacteria such as Vibrio cholerae increased during late 
1990s. An example of this probable microbial transport by ships is when V. cholerae O139 
serotype was detected in association with shellfish and fish in the Gulf of Mexico [9]. This 
serogroup was not detected prior to the incident in the gulf. However, at the same time, an 
epidemic caused by V. cholerae O139 was underway in South America. When ships arriving 
from South America were sampled in Mobile Bay, Alabama, their ballast water contained a 
strain of V. cholerae O139 [9]. Their ballast water was subsequently analyzed to characterize this 
V. cholerae strain. It was demonstrated that this strain was indistinguishable from the strain 
found in Gulf fish and shellfish. Fortunately, no illnesses were reported in the US from this 
strain, but the incidents demonstrated the potential for ships to transport viable, toxic bacteria.  
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1.4 Aim of this project  
The purpose of this study is to establish optimal growth conditions, including incubation 
time and temperature for detecting Enterococcus faecalis in water collected from the natural 
environment. This search for establishment of optimal growth conditions of E. faecalis became 
crucial after discrepancies in the scientific literature was observed. Different temperatures and 
incubation times are recommended by US EPA, National Standard Methods of Great Britain, and 





2. Materials and Methods 
2.1 What methods have previously been used and discrepancies observed 
Current United States Environmental Protection Agency (USEPA) and European Union methods 
call for membrane filtration and incubation of the filters on selective media specific for growth 
of enterococci (modified Enterococcus agar, mEA). The main method used for detection of 
Enterococcus faecalis is the membrane filtration-based USEPA Method 1600 on mEI agar [23]. 
This method states that 0.1 mL, 1mL and 10 mL of water to be tested needs to pass through 0.45 
µm nitrocellulose membrane, which is then transferred onto mEnterococcus agar and incubated. 
The real question arose when we examined scientific literature for the incubation conditions of 
the membrane filtration method. Table 1 summarizes the discrepancies observed in the scientific 
literature for incubation conditions of E. faecalis. 
 
* National Standard Methods (Great Britain)  
** Second edition Difco& BBL Manual 2009 
Table 1. Summary of incubation conditions for E. faecalis 
 mEA EIA 
 T °C Time T°C time 
NHS* drinking water  
37° 
 









44° 4 h 
mEA datasheet 
(2005) 
35° 48 h Nd Nd  
                            
(2009) 
41°** 48 h 41° 20 min 
EPA (2002) 41° 48 h 41° 20-30 min 
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2.2 Methods developed in this project 
To establish optimal growth conditions of E. faecalis for the membrane filtration method, 5 
liters of water were collected from Lake Artemesia, College Park, MD. This water was then 
passed through filters using 0.2 µm Isopore
TM
 membrane and aliquots of 1L were collected in 
sterile bottles that were then stored at 4°C. E. faecalis ATCC 29212 (CP1133) was grown on 
Lysogeny Broth (LB) agar media. The use of 0.2 µm Isopore
TM
 membranes ensures the 
sterilization, removal of most of the bacteria present, of the collected water without eliminating 
nutrients present in the sample.  A single colony was collected and placed in 5 mL of LB broth 
and incubated overnight at 37°C with shaking for constant aeration of the bacteria. Two mL of 
the overnight culture were washed twice 1X Phosphate Buffered Saline (PBS, Cold Spring 
Harbored protocols, 2006) at 8000 rpm and then resuspended in 2 ml of 1X PBS. Cell density of 
CP133 was then measured by a spectrophotometer at 600 nm (OD600). To obtain a better 




) in 1X PBS were prepared and read (Blank was 1X 
PBS). The obtained reading was then converted to cfu/mL using the following formula: 
1 OD600 = 5 x 10
8
 cell/mL 
0.1mL, 1mL and 10mL of filtered Lake Artemesia water was then amended with 10 CFU/mL of 
strain CP1133 and filtered using a Millipore multichannel filter holder vacuum manifold and a 
0.45 µm membrane. The membranes where then placed on mEA agar and incubated under three 
different conditions: 35°C for 24 hours, 35°C for 48 hours, and 41°C for 48h, in order to test the 
different methods present in the literature (see Table 1). Colony count was then performed at the 
end of each incubation, to compare the results. Experiments were performed in triplicates.  
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2.3 Statistical analysis of the data 
Statistical analysis was conducted using STATA 12.0 statistical software package at 95% 
confidence intervals. Pearson correlation was used to establish linear relationship between all 
variables included in the regression analyses and possible multicollinear between environmental 
variables. Descriptive statistics were used to estimate mean and standard deviation for all 
variables included in the model. A multiple linear model (GLM) was used to model the data. 
Choice of model was based on the overall regression Chi-square statistic, significance of 
individual variable coefficient estimate at the 95% confidence level, and R
2
, as well as lower 
error.  
The multiple regression model for k predictors is as follows: 










3. Results and Discussion 
To establish optimum growth conditions E. faecalis ATCC 29212 was used in a series of 
experiments that employed membrane filtration and three different incubation conditions: 35°C 
for 24hours, 35°C for 48 hours, and 41°C for 48 hours. Results from three separate experiments 
are presented in Table 2. 




Test 1 Test 2 Test 3 Average 
Corrected 
Average 







 (cfu/mL)  (cfu/mL) 
            
0.1 mL 2 0 0 0.666666667 1 
1 mL 11 11 13 11.66666667 12 
10 mL 106 114 105 108.3333333 108 
35 ° C /48hrs 
            
0.1 mL 1 0 1 0.666666667 1 
1 mL 13 12 15 13.33333333 13 
10 mL 117 118 143 126 126 
41 ° C / 48hrs 
            
0.1 mL 0 0 0 0 0 
1 mL 0 0 0 0 0 
10 mL 30 3 10 43 43 
 
The selected E. faecalis, strain showed preference for 35°C incubation temperature over 41°C 
incubation temperature. In all of the three experiments, E. faecalis had minimal or no growth 
under 41°C for 48hrs. Plates are observed after 48hrs to enumerate E. faecalis ATCC 29212 and 
no red colonies were observed.  This is while dark red colonies were observed after incubation at 
35°C for both 24 and 48 hours. However, depending on the extent of the incubation time the size 
of these colonies differ where bigger colonies were observed after 48 hours as compared to 24 
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hours of incubation. A comparison in growth of the colonies incubated under different conditions 
can be observed in figure 1 and 2. 
 
 
Figure 1. Membrane filteration 
method used in this experiment 
where 1 L of filtered lake 
Artemesia water was amended 
with 100 cfu/mL and filtered using 
0.45 µm filters and placed on mEA 
agar plates. The plate shown on the 
top of the page was incubated at 
37°C for 24hrs after incubation. 
There are 74 colonies of E. faecalis 
(ATCC 29212) present on the 
plate. The color of the colonies is 
dark red and the shapes size and 
shape of them are consistent with 
the species characteristics. The 
plate shown on the bottom of the 
page has 70 colonies present on the 
plate that contain the same species 
as the plate on the top of the page 
with the difference in the 
incubation condition. This bottom 
plate was incubated at 37°C for 
48hrs. The increase in the time of 
incubation has resulted in colonies 
that are a little bigger consistent 





Figure 3 is a comparison of different incubation conditions for detection of E. faecalis for each 
of the different volumes filtered (the dilution factor was taken into an account when performing 
these analysis).  To analyze the findings of this experiment results shown in table 2 were 
compared by volume, time of incubation (24hours and 48 hours) and temperature of incubation 
(35°C and 41°C ) used in this experiment. It is demonstrated here that there is no difference in 
the observations, in regards to volume and time of incubation used, as the bars representing each 
volume and also the same ttemperature have nearly identical hights. However, there is a 
difference in the tenperatures employed in this experiment as shown by the yellow stars in the 




Figure 2. Figure 1. Membrane 
filtration method used in this 
experiment where, 1 L of filtered 
lake Artemesia water was spiked 
with 100 cfu/mL and filtered using 
0.45 µm filters and placed on mEA 
agar plates. The plate shown on the 
top of the page was incubated at 
37°C for 24hrs after incubation. 
There are 32 colonies of E. faecalis 
(ATCC 29212) present on the 
plate. This plate was incubated at 




Figure 3. Comparison of different incubation conditions for the growth of E. faecalis. 
 
A one way analysis of variance and a three way analysis of variances were employed to 
analyze the variables, namely time, temperature, and volume and using three independent tests 
(The means and standard deviations are presented in Table 3 and Table 4 demonstrate analysis of 
variance).  
Table 3: Means and standard deviations of Temp, Time and Volume. 
Variable Obs Mean Std. Dev. Min Max 
Temp 27 37 2.882307 35 41 
Time 27 40 11.52923 24 48 
Volume 27 37 45.55048 0.1 10 
enterococci 27 81.81481 58.65416 0 200 
 
Table 4: Analysis of Variance (Anova one way factorial) 
Source    Partial SS     df        MS            F      Prob > F 
Model    77142.2407      1 77142.2407      156.72      0.0000 
Temp    77142.2407      1 77142.2407      156.72      0.0000 
Residual    12305.8333     25   492.233333      




Number of obs = 27 
 R-squared = 0.8624 
  Adj R-squared =  0.8569 
Root MSE      = 22.1863 
      
The data from this experiment is properly described by the following statistical model: 
Yij = μ + Ti + eij 
Where Ti is the fixed effect of i
th
 temp, Yij is the outcome variable (bacterial count) 
The one way-factor analysis of variance shows significant main effect for Temp, F(1,26) = 
156.72, p-value < 0.05. A good model can be formulated from the above data that can describe 
about 85% of the model variance. On the other hand, when the three way-factor analysis of 
variance was used, the main effect of both time and volume showed no significant effect (p-value 
> 0.05). A three and two-factor analysis of variance showed no significant effect of the 
interactions between temperature, time and volume (p-value > .05).  
In summary, the results demonstrate that there is no significant difference in the time and 
volume employed, whereas there is a significant difference between the two incubation 
temperatures (35°C and 41°) employed (p-value < 0.05). Therefore, it is concluded that 





Fecal indicators are used as indicators for the presence of fecal contamination in water 
samples collected from the environment. Organisms commonly used for detection of the 
presence of fecal contamination as proxies for the presence of human enteric pathogens are E. 
coli and Enterococcus faecalis as also recommended by the United States EPA. Similarly, 
international and United States regulations for ships’ ballast water discharge include acceptable 
limits for E. coli and Enterococci since both of these organisms are used in ballast water 
treatment analysis. There is a serious inconsistency of methods recommended for detecting the 
presence of E. faecalis in surface waters which led us to conduct the present study to establish an 
optimal growth condition for the detection of E. faecalis in environmental water samples using 
membrane filtration technique. Results indicate that there is a significant difference between the 
temperatures employed (35°C and 41°C) for growth of E. faecalis (p-value <0.05) with no 
apparent difference in the incubation time (24hrs and 48 hours). Therefore, it is concluded that 
incubation for 24 hour at 35°C may be adequate for enumeration of these pathogens. This will 
not only speed up tests that involve detection and enumeration of Enterococci but will also 







1.1 Antibiotic resistance patterns in V. cholerae 
Vibrio cholerae is a gram negative, non-spore forming, curved rod, highly mobile with a 
single polar flagellum in coastal waters and estuaries. V. cholerae have a simple nutritional 
requirement, which allows them to grow rapidly, with a generation time of less than 30 minutes. 
They not only can grow in high numbers if they are generously aerated, but they can also grow 
under anaerobic conditions. V. cholerae is sensitive to low pH but are quite tolerant of alkaline 
conditions.[24] V. cholerae grow optimally in the presence of salt, however, the organism can 
also grow in warm low salinity water that contains sufficient organic nutrients. Presence of V. 
cholerae in water is primarily associated with zooplankton and shellfish where they can also 
enter viable but non-culturable forms [24]. This bacterium has different serotypes with O1 
(classical and El Tor biotypes) and O139 being the toxigenic serogroups primarily responsible 
for cholera epidemic that carry cholera toxin producing genes in their genome. The acute 
diarrheal cholera was responsible for approximately 7816 deaths worldwide in 2011 mainly 
affecting the health of young children between the ages of 1 and 5 years [25]. V. cholerae can be 
transmitted easily in the community by water and secondary transmission via the fecal-oral route, 
in absence of proper sanitary systems, particularly in developing countries. 
V. cholerae does not normally cause systemic infection and therefore antibiotics are not 
essential in treatment. However, it is beneficial to combine oral rehydration therapy with 
antibiotic treatment since they lessen the duration of illness and reduce shedding of V. cholerae 
in the stool[26]. Most commonly used antibiotics in cholera therapy are tetracycline, 
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furazolidone, ampicillin, and ciprofloxacin and V. cholerae O1 strains from studies done in India 
have shown resistance against.[27] Results from other studies in Argentina and India have shown 
that isolates of V. cholerae have developed resistance towards ceftriaxone. These studies together 
demonstrate the rapid change that’s occurring in the antimicrobial susceptibility patterns of V. 
cholerae O1 strains [27]. 
After 1980s, high levels of resistance to commonly used tetracycline, ampicillin, 
sulphonamides and nalidixic acid were observed among different strains of V. cholerae and 
linked to plasmid encoded genes. The widespread use of these antibiotics and the ease of access 
were the selective pressures that gave rise to multi-drug resistant V. cholerae strains. After V. 
cholerae O139 emerged in June 1992 in India [27], a variability in the susceptibility patterns of 
O1 strains and higher proportions of multidrug resistant strains were observed. Continued 
surveillance revealed a different resistance pattern wherein the strains were more frequently 
resistant to tetracycline and ampicillin. The emerging strains possessed extra genetic elements 
which indicate that significant genomic changes have occurred. Recent strains have shown an 
increasing trend of resistance to fluoroquinolones. These findings suggest that there has been 
substantial mobility of genetic elements in V. cholerae, which could have contributed to the 
emerging drug resistance [27]. 
Studies performed by Materu et al in different sites of six countries of eastern Africa 
during 1994-1996 on antibiotic susceptibility of V. cholerae, also demonstrated resistance to 
tetracycline, chloramphenicol and cotrimoxazole, nalidixic acid and erythromycin [28]. A similar 
study was performed in Nepal by Shrestha et al. in 2005 were all V. cholerae strains isolated 
were found resistant to be multidrug resistant to nalidixic acid, cotrimoxazole, and furazolidone 
[29]. The variations present in resistance patterns within countries and different regions 
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demonstrate how different sets of events and factors play a role and affect antibiotic 
susceptibility patterns of the bacterium [28]. Patterns of resistance are also different between 
different strains of V. cholerae. Researchers have suggested that the toxigenic strains are more 
likely to maintain antibiotic resistance because of the selective pressure that therapeutic 
treatments apply on them. This is while the non-toxigenic strains tend to maintain their resistance 
elements in the natural state in the environment with less antibiotic contact [30]. 
Multidrug resistant strains of V. cholerae O139 have traditionally been associated with 
the acquisition of R plasmids that belong to conjugative groups. Class I integrons and Integrative 
Conjugative Elements (ICEs) are other factors that are closely related with the transfer and 
spread of antibiotic resistant genes among V. cholerae [31]. Integrons are non-mobile genetic 
elements with open reading frames embedded in exogenous gene cassettes that are often found 
within conjugative plasmids. Integrons are considered assembly platforms that have the ability to 
acquire open reading frames that are embedded in exogenous gene cassettes. This transforms the 
exogenous open reading frame to functional genes by ensuring their correct expression.[32] The 
ICE SXT is a conjugative, self-transmissible and integrating element that was originally found in 
the chromosome of toxigenic V. cholerae O139 strain encoding for sulfamethoxazole, 
trimethoprim, chloramphenicol, and streptomycin resistances [33]. Empty SXT-related elements 
are capable of obtaining both antibiotic resistance genes and also other virulence factors giving it 
an easy route to be transferred to other strains through conjugation [32]. This emphasizes on the 
ability of antibiotics to promote the spread of antibiotic resistance genes, resulting in high 
antibiotic resistance and a need for close monitoring of the genes. 
More recently some cases of resistance to third-generation cephalosporins in Gram-
negative bacteria have been observed, possibly related to Extended Spectrum Beta-Lactamases 
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(ESBL), efflux pumps, and chromosomal mutation. The reduced susceptibility to cephalosporins 
can be chromosomally mediated involving the same mechanisms that have been observed in 
chromosomally mediated penicillin resistance [27]. Organisms bearing the most problematic 
resistance to extended-spectrum β-lactamases are Pseudomonas aeruginosa, Acinetobacter 
baumannii, Escherichia coli and Klebsiella pneumonia [34].  
 
1.2  Β-lactam antibiotics and their importance 
 
Infections caused by Gram-negative bacteria resistant to β-lactams are becoming more 
alarming over the recent years. β-lactam antibiotics can be mostly divided into two groups: 
enzymes with a serine residue at the active site and metallo-enzymes with zinc ion as a cofactor 
[35]. Each of these groups are evolutionarily distinct. Serine bearing enzymes are similar to 
bacterial penicillin-binding proteins which are hypothesized as theirs source of origin [35]. β-
lactams antibiotics inhibit cell wall synthesis. These antibiotics are sterically similar to a class of 
the glycan component of the peptidoglycan matrix of the bacterial cell wall and interfere with 
cell wall synthesis. This subsequently leads to a change in the permeability of the bacterial cell 
wall to water and therefore, they rapidly take up fluid, and eventually lyse [36]. 
Penicillins such as amoxicillin, oral cephalosporins such as cefpodoxime and cefuroxime, 
parenteral cephalosporins such as cefepime and ceftriaxone, and the carbapenems such as 
doripenem, ertapenem, imipenem, and meropenem are among the β-lactam antibiotics mostly 





Table 5. β-lactam classification scheme 
Common β-lactam Antibiotics 


















Fourth Generation Cefepim 
Fifth Generation  
Carbapenems and 
Carbacephems 
  Imipenem 
Monobactems   Aztreonam 
 
Penicillins are β-lactam antibiotics that are used in the treatment of bacterial infections 
caused by susceptible, usually Gram-positive, organisms. They have a penam nucleus that 
consists of a 4-membered β-lactam ring that is fused to a 5-membered thiazolidine ring. As new 
pathogens that were resistant to β-lactam antibiotics, emerged and disseminated therapeutic 
demands for new antibiotics arose and resulted in the expansion of β-lactams. Cephalosporins 
have a cephem nucleus that is comprised of a β-lactam ring that is fused to a 6-membered 
dihydrothiazine ring. New cephalosposins are principally designed by structural modifications at 
C-3 and C-7, which are responsible for lipophilic and basic properties [37]. Cephalosporins are 
generally classified into groups called “generations” and each newer generation has significantly 
greater Gram-negative antimicrobial properties than the preceding generation, in most cases with 
decreased activity against Gram-positive organisms. Currently fifth generation cephalosporins 
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are the most effective β-lactams with broad spectrum with the ability to treat Methicillin-resistant 
Staphylococcus aureus (MRSA) [38].   
Carbapenems are relatively new class of β-lactam antibiotics that differ from penecillins and 
cephalosporins in their chemical structure and offer a broad spectrum of activity [39]. This broad 
spectrum activity has been linked to affinity of carbapenems for penicillin-binding proteins, their 
ability to permeate cell membrane of multiple gram-negative bacilli, and their resistance to a 
broad range of beta-lactamases from gram-positive and gram-negative bacilli [40]. Carbapenem 
use has increased as a result of the rising resistance to cephalosporin antibiotics in 
Enterobacteriaceae that is largely due to the spread of extended spectrum βlactamases, which can 
hydrolyze them. 
 
1.3 Different mechanisms of resistance to beta-lactams 
Bacteria are either naturally resistant to some antibiotics or they acquire resistance genes 
from their external environment. A mix of mutations, antibiotic modifications and antibiotic 
resistance genes (ARGs) uptake can lead bacteria to gain antibiotic resistance that they don't 
have intrinsically[41]. 
An example of the intrinsic antibiotic resistance is the natural resistance of Enterococci to 
cephalosporins that is the result of its decreased binding affinity to the penicillin-binding 
proteins. Mutations of regulatory and structural genes as well as acquisition of resistant genes 
from the external environment are considered to be the main sources of acquiring antibiotic 
resistance genes in bacteria [41]. Point mutations are a source of antibiotic resistance in bacteria 
where an alteration in the binding affinity of antibiotics is observed. The binding affinity of 
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quinolones and β-lactams are greatly affected by point mutations resulting in production of 
hundreds of new enzymes with varying degrees of resistance [41]. 
Sources of bacterial resistance to antibiotics other than mutation are degradation or 
modification of the antimicrobial, decreased uptake of an antimicrobial and active efflux of an 
antimicrobial out of the cell. Changes in antimicrobials or their degradation are two commonly 
observed resistance mechanisms which lead to elimination or reduction of antimicrobial activity 
[42]. β-lactamases for example cleave the b-lactam ring and consequently lead to antimicrobial 
activity. Various mechanisms leading to enzymatic modifications and subsequently inactivation 
of antibiotics exist, with acetylation being one of the most common. Enzymes employing these 
mechanisms sometimes have a dual function; acetylating the antimicrobial and also interfering 
with translation and protein synthesis. Antibiotic resistance in Gram-negative bacteria has also 
been associated with reduced bacterial cell permeability, mainly via porin modifications. Porins 
are channels on the cell membrane that allow the entry for molecules internally and depend on 
charge, shape, and size of the entering molecule. Loss of function mutation in these outer 
membrane proteins often result in antibiotic resistance. In addition, mutations in the genes that 
encode the outer membrane lipopolysaccharides (LPS) can also lead to antibiotic resistance [41].  
Active efflux of an antimicrobial out of the bacterial cell is a commonly used strategy by 
gram negative bacteria to decrease the internal concentration of antimicrobial agents. This 
method is used by β-lactamases and is an energy dependent process [43]. Efflux pumps are 
naturally occurring in bacteria and in Gram-negative bacteria they are often chromosomally 
encoded. Multi-drug resistance can specially be linked to efflux mechanisms. Efflux mediated 
resistance can be due to mutations in either the regulatory or effector genes of the efflux system 
or mutations resulting in increased expression of the efflux pump protein or increased efficiency 
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of the pump in exporting antimicrobials out of the cell [44]. Genes encoding efflux pump 
proteins are either carried on chromosomes or on transmissible genetic elements, and therefore 
can be constitutively expressed or triggered by stimuli present in the environment [26]. 
β-lactamase encoding genes are located on either the bacterial chromosome, on plasmids, 
or on transposons. These β-lactamase encoding genes (bla) can be either constitutively produced 
or be induced by environmental stimuli. β-lactamase genes have also been associated with 
integrons and play an important role in the spread of β-lactam genes. These non-mobile elements 
have variable length with a 5′ conserved integrase gene, gene cassettes containing information 
for resistance to antibiotics, and an integration site for the gene cassette [36]. Integrons use 
mobile elements such as plasmids to serve as vehicles for their transport. Plasmids are not vital 
for the survival of bacteria, but they generally transport genes that are advantageous to the 
bacteria such as virulence determinants and antibiotic resistance genes. Plasmids that carry 
resistance genes are called R plasmids [41].  
In summary, resistance to β-lactam antibiotics can be the result of the mechanisms 
described above with the most common ones being the production of β-lactamase enzymes 




β-lactamases are classified either based on function (the system of Bush-Jacoby-
Medeiros) or based on their structure (Ambler classification). Ambler classification divides the 
β-lactamases into four groups: class A, B, C, and D enzymes [34]. Class A enzymes consists of 
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penicillinases including the SHV-1 enzyme in Klebsiella pneumoniae and the TEM-1 β-
lactamase found in many strains of Neisseria gonorrheae and Haemophilus influenza [45]. These 
enzymes are readily inhibited by clavulanic acid, sulbactam, and tazobactam. The class B are 
metallolactamases that use one of two zinc (Zn2+) atoms for inactivating penicillins and 
cephalosporins. They are resistant to carbapenems, cephalosporins and penicillins and are 
susceptible to inhibition by EDTA, however, they are not susceptible to inhibition by clavulanic 
acid or sulfones [34, 36]. MBL that have clinical importance and have a high prevalence are the 
IMP-type and VIM-type of Pseudomonas aeruginosa. Class C enzymes include AmpC type 
beta-lactamases found in Citrobacter freundii, Enterobacter aerogenes, Enterobacter cloacae, 
Morganella morganii, Pseudomonas aeruginosa and Serratia marcescens [36]. AmpC beta-
lactamases confer resistance to penicillins, beta-lactamase inhibitors, cefoxitin, cefotetan, 
ceftazidime, ceftriaxone, and cefotaxime. Aztreonam and cefepime. Ambler class D enzymes are 
serine beta-lactamases that are able to hydrolyze oxacillin and have been found in only a few 
species such as Pseudomonas aeruginosa, Acinetobacter spp., and Aeromonas spp [34]. 
Depending on the OXA enzyme, these beta-lactamases confer resistance to penicillins, 
cephalosporins, extended-spectrum cephalosporins or carbapenems. OXA enzymes are relatively 
resistant to clavulanic acid inactivation, but are inhibited by sodium chloride [36]. A summary of 
both the classification schemes of β-Lactamase antibiotics can be found in Table 6. 
 
1.3.2 Extended Spectrum β-Lactamases 
The most concerning β-lactamases belong to the group Extended-Spectrum β-Lactamases 
(ESBL) (functional group 2be or molecular class A). Initially, variations in the common SHV-1 
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and TEM-1 β-lactamases gave rise to ESBLs that were found to be different from their parent 
enzymes by one or two amino acids. They are mostly associated with major outbreaks of 
cephalosporin-resistant infections caused by ESBL-producing E. coli and K. pneumoniae. 
Plasmids conferring resistance to multiple antibiotic classes carry the genes that code for 
these enzymes and are readily transferable among species. Other members of the 
Enterobacteriaceae group such as Citrobacter freundii, Enterobacter aerogenes, and Serratia 
marcescens are classified as ESBL producing organisms [45]. 
Table 6. Beta-lactamase classification schemes[46] 
Ambler classification system 
 class A penicillinases 
TEMs, SHVs,PC1, CTX-Ms, 
SME-1, KPC-1 
 class B metallo-beta-lactamases (zinc) IMP-1, VIM-1,Ccr A 
 class C cephalosporinases AmpCs, CMY-2, ACT-1 
 class D oxacillinases OXA-1 
      
Bush-Jacoby-Medeiros classification 
 Group 1 cephalosporinases AmpCs, CMY-2, ACT-1, MIR-1 
  
hydrolyze extended-spectrum cephalosporins; 
clavulanate resistant   
 Group 2 all clavulanic acid susceptible   
  2a penicillinase PC1 from S. aureus 
  2b broad-spectrum penicillinase TEM-1, SHV-1, TEM-2 
  2be ESBLs SHV-2, TEM-10, CTX-Ms 
  2br inhibitor resistant TEMs, IRTs TEM-30, TEM-31 
  2c carbenecillin hydrolyzing PSE-1 
  2d oxacillin hydrolyzing OXA-10, OXA-1 
  2e cephalosporinases inhibited by clavulanate FEC-1 
  2f carbapenemases KPC-1, SME-1 
 Group 3 metallo-beta-lactamases IMP-1, VIM-1, Ccr A 
  
hydrolyze imipenem,inhibited by EDTA, 
resistant to clavulanate   





More recently outbreaks caused by gram negative β-lactam resistant bacteria have been 
associated with CTX-M family of ESBLs instead of the original SHV and TEM variants. The 
initial CTX-M-producing isolates conferred resistance to cefotaxime and ceftriaxone but were 
susceptible to ceftazidime. Class I integron-associated orf513 seems to be involved in the 
mobilization of blaCTX-M genes [45]. However, a single amino acid mutation in some members 
of the CTX-M family resulted in high rates of hydrolysis of extended-spectrum cephalosporins 
and consequently resulted in complete cephalosporin resistance in all pathogenic members [45]. 
A regional variation exists in the emergence of the CTX-M family that is a result of the selective 
pressure exerted by localized preferences for therapeutic agents [35].  
There are many different TEM-type, SHV-type, and non-TEM, non-SHV type ESBLs 
reported. For example, it has been shown that cefepime can be hydrolyzed by SHV-2 and SHV-5 
or TEM-24 β-lactamases. Thus far, more than 40 unique CTX-M type beta-lactamases have been 
discovered that are divided into five groups: CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9, and 
CTX-M-25 group[47]. Researchers have related the emergence of CTX-M ESBLs to acquisition 
of plasmids by preexisting chromosomal ESBL genes from the Kluyvera spp. CTX-M beta-
lactamases are mainly found in K. pneumoniae, E. coli, thyphoidal and nonthyphoidal 
Salmonella, Shigella, C. freundii, Enterobacter spp., and S. marcescens.[36]  
ESBL detection is the main challenge microbiologist face in the laboratory. This is due to 
factors such as the location of the genes carrying information for the production of ESBLs on 
plasmids, integrons and other mobile elements and also challenges that exist in obtaining pure 
cultures, especially when environmental samples are being handled [48]. Micro-dilution method 
is one of the major testing methods being used and disc diffusion is another commonly used 





Metallo-β-lactamases (MBL) are zinc-requiring chromosomal enzymes that were initially 
associated with other β-lactamases that generally had higher hydrolysis rates for penicillins and 
cephalosporins [49]. Even though these enzymes have a relatively weak β-lactamase activity 
against all β-lactams except aztreonam, they have a unique ability to hydrolyze carbapenems. 
Stenotrophomonas maltophilia, Aeromonas spp., and a small population of Bacteroides fragilis 
are organisms that confer resistance to carbapenems [32].  
IMP and VIM are clinically important MBLs that can be inhibited in vitro by chelating 
agents like EDTA, but cannot be inactivated by clavulanic acid or other clinically useful 
inhibitor compounds [36]. IMP-1 is a plasmid-encoded MBL with clinical importance 
internationally that has 26 variants. The VIM family of MBLs has 23 variants and has been 
associated with many of the Enterobacteriaceae, including Enterobacter spp., E. coli, C. 
freundii, Klebsiella spp., and S. marcescens P. aeruginosa and Acinetobacter baumannii [32]. 
These genes are often carried on integrons that contain multiple antibiotic resistance 
determinants and are therefore, easily transferrable among species. MBL genes rely on the 
selective pressure exerted by the use of antibiotics such as carbapenems and consequently can be 
lost in the absence of this pressure[32, 50] . This is more relevant among species specific MBL 
that carry their genes on plasmids producing one other β-lactamase with an overlapping 
hydrolysis profile. Other important MBLs include SPM, and GIM. 
A novel MBL named NDM-1 (NDM-1) is a newly-described metallo-beta-lactamase 
(MBL), first identified in 2008 in single isolates of Klebsiella pneumoniae and Escherichia coli 
from a Swedish patient who was transferred from India [51]. NDM-1 is an acquired MBL that 
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has the ability to hydrolyze all β-lactam antibiotics (except aztreonam). Resistance to antibiotics 
can extensively increase in Enterobacteriaceae carrying blaNDM-1 when they couple this 
acquired MBL resistance mechanism with other resistant mechanisms. This becomes worrisome 
since the spread of multidrug resistant Enterobacteriaceae leave clinicians few or no therapeutic 
options[51].  NDM-1 is distantly related to enzymes VIM-1 and VIM-2, with  32% amino acid 
identity [52]. The first case of a polymicrobial NDM-1 positive V. cholerae was reported in 2012 
by Darley et al. rising concerns [53]. 
 
1.3.4 Carbapenemases 
Three major carbapenems are available for clinical use: imipenem, meropenem and 
ertapenem, and there are two major classes of carbapenemases, the serine carbapenemases and 
the Klebsiella pneumoniae carbapenemase (KPC) [36]. Serine carbapenemases enzymes have a 
broad range of antibacterial activity with the ability to hydrolyze most β-lactam antibiotics and 
the ability to act as beta-lactamase inhibitors. Serine carbapenemases can be plasmid-encoded or 
chromosomal, and have been associated with K. pneumoniae, Enterobacteriaceae as well as P. 
aeruginosa, Acinetobacter spp., S. marcescens and Enterobacter spp [32, 36].  
 Klebsiella pneumoniae carbapenemases are growing clinical concerns and have been 
related to infections involving K. pneumoniae, Salmonella enterica serotype Cubana, Klebsiella 
oxytoca and Enterobacter spp [36]. Even though KPC-1 beta-lactamase confers high-level 
resistance to carbapenems, it is difficult to correctly detect these enzymes. The organisms 
carrying KPC-1 beta-lactamase usually confer resistance to imipenem, meropenem, 
amoxicillin/clavulanic acid, piperacillin/tazobactam, ceftazidime, aztreonam, and ceftriaxone 
[36]. KPC encoding genes are often found on conjugative and non-conjugative plasmid in 
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association with other genes [54]. For example, KPC-1 genes have previously been found with 
SHV-29 and TEM-1 beta-lactamases [36]. With this genetic support, it is easy to understand the 
concern for widespread dissemination. This increases the concerns associated with infections 
involving KPCs and emphasizes the need to monitor and study these enzymes. In some studies 
surveying organisms carrying KPC resistant genes, resistance to extended-spectrum 
cephalosporins, fluoroquinolones and aminoglycosides have also been observed [54].  
 
1.3.5 Overcoming beta-lactamase resistance 
Clinicians employ two strategies to overcome the effect of β-lactamases. In the first method uses 
inhibitors of β-lactamases in combination with the antibiotic beta-lactam. These inhibitors are 
structurally similar to penicillins and get trapped in the β-lactamase, for which they have a high 
affinity [55]. The inhibitor undergoes slow hydrolysis by the beta-lactamase with a different 
reaction chemistry than β-lactams and therefore, occupies the active site longer[36]. The beta-
lactam is then able to do is job. 
There are three inhibitors currently being employed by clinicians: clavulanic acid, 
sulbactam, and tazobactam [55]. For example amoxicillin-clavulanic acid is a combination that is 
mainly used in the treatment of community infections and piperacillin-tazobactam is another 
combination that is used in treatment of serious hospital-acquired infections [32]. 
The second strategy employs new beta-lactam antibiotics that form an efficient 
permeability barrier and is not hydrolyzed by beta-lactamases [36]. β-Lactams intervene in the 
biosynthesis of peptidoglycan and are highly specific, since the structure of peptidoglycan solely 
belongs to the bacterial world. Therefore, creating a new compound that has similar properties 
32 
 
but instead stabilizes the permeability of the external cytoplasmic membrane[55], unlike β-
lactamases, is a useful strategy that scientists have used in creating compounds such as extended-
spectrum cephalosporins or carbapenems.  
 
1.4 beta-lactam resistance in V. cholerae 
 In August of 2012 Mandal et al. reported the first case of Vibrio cholerae carrying NDM-1 gene 
in India. This V. cholerae strain contained both metallo beta-lactamase-1 (blaNDM-1) and 
plasmid-mediated beta-lactamase-1 (blaDHA-1). This was followed by another report, in 
October of 2012, by Darley et al. of a non-01, non-0139, NDM-1 positive V. cholerae in England 
that was carried there through a patient from India. These reports caused major concerns 
regarding multi-resistant resistant V. cholerae and emphasized the need for monitoring V. 
cholerae strains. 
 
1.5 Aim of this project 
Being the etiological agent of cholera, V. cholerae O1 is a major public health problem in 
several developing countries. Extended-spectrum β-lactamases (ESBL) are resistance 
determinants of increasing clinical relevance in Gram-negative bacteria. Because of their broad 
range, these enzymes can confer resistance to almost all beta-lactams in pathogenic bacteria.  
The recent alarming discovery of blaNDM circulating in V. cholerae O1 and non-
O1/non-O139 strains in India, by Mandal et al. and Darley et al., raised the question of whether 
these antibiotic resistance determinants were circulating also in this species. Therefore, in this 
study the β-lactam resistance profile of a wide collection of V. cholerae O1 strains isolated from 
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clinical and water samples from an ongoing project in Bangladesh were analyzed to determine 
resistance pattern among the strains.  
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2. Materials and Methods 
2.1 Strain collection 
A collection of 210 V. cholerae O1 strains, isolated from clinical and water samples from 
an ongoing epidemiological and ecological cholera surveillance in Bangladesh, from Chhatak 
and Mathbaria between March 2009 and April 2012 were investigated. Figure 4 is a map of 
Bangladesh with cholera surveillance sites in the provinces of Chhatak and Mathbaria indication 
the number of environmental and clinical strains and table 6 lists all the strains collected for this 
study, the location that the strain was collected, and whether the strain is clinical or 








V. cholerae  O1  
Clinical 68 
Environmental 6 
V. cholerae O1  
Clinical 77 
Environmental  57 
 Mathbaria 
 
Figure 4. Map of Bangladesh and cholera surveillance 
sites in the provinces of Chhatak and Mathbaria. 
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              Table 7. List of strains used in this study. 
Strain Original ID Place Year Clin/Env Type Sero 
1559 NHCC-01 Chhatak 2009 Clin O1 OGET* 
1562 NHCC-04 Chhatak 2009 Clin O1 OGET 
1563 NHCC-05 Chhatak 2010 Clin O1 OGET 
1564 NHCC-06 Chhatak 2010 Clin O1 OGET 
1566 NHCC-08 Chhatak 2010 Clin O1 OGET 
1567 NHCC-09 Chhatak 2010 Clin O1 OGET 
1568 NHCC-10 Chhatak 2010 Clin O1 OGET 
1569 NHCC-11 Chhatak 2010 Clin O1 OGET 
1570 NHCC-12 Chhatak 2010 Clin O1 OGET 
1571 NHCC-13 Chhatak 2010 Clin O1 OGET 
1572 NHCC-14 Chhatak 2010 Clin O1 OGET 
1573 NHCC-15 Chhatak 2010 Clin O1 OGET 
1574 NHCC-16 Chhatak 2010 Clin O1 OGET 
1576 NHCC-18 Chhatak 2010 Clin O1 OGET 
1577 NHCC-19 Chhatak 2010 Clin O1 OGET 
1578 NHCC-20 Chhatak 2010 Clin O1 OGET 
1579 NHCC-21 Chhatak 2010 Clin O1 OGET 
1580 NHCC-22 Chhatak 2010 Clin O1 OGET 
1581 NHCC-23 Chhatak 2010 Clin O1 OGET 
1585 NHCC-27 Chhatak 2010 Clin O1 OGET 
1586 NHCC-28 Chhatak 2010 Clin O1 OGET 
1587 NHCC-29 Chhatak 2010 Clin O1 OGET 
1588 NHCC-30 Chhatak 2010 Clin O1 OGET 
1589 NHCC-31 Chhatak 2010 Clin O1 OGET 
1590 NHCC-32 Chhatak 2010 Clin O1 OGET 
1591 NHCC-33 Chhatak 2010 Clin O1 OGET 
1592 NHCC-34 Chhatak 2010 Clin O1 OGET 
1593 NHCC-35 Chhatak 2010 Clin O1 OGET 
1594 NHCC-36 Chhatak 2010 Clin O1 OGET 
1596 NHCC-38 Chhatak 2010 Clin O1 OGET 
1597 NHCC-39 Chhatak 2010 Clin O1 OGET 
1598 NHCC-40 Chhatak 2010 Clin O1 OGET 
1599 NHCC-41 Chhatak 2010 Clin O1 OGET 
1600 NHCC-42 Chhatak 2010 Clin O1 OGET 
1601 NHCC-43 Chhatak 2010 Clin O1 OGET 
1602 NHCC-44 Chhatak 2010 Clin O1 OGET 
1603 NHCC-45 Chhatak 2010 Clin O1 OGET 
1604 NHCC-46 Chhatak 2010 Clin O1 OGET 
1605 NHCC-47 Chhatak 2010 Clin O1 OGET 
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1606 NHCC-48 Chhatak 2010 Clin O1 OGET 
1607 NHCC-49 Chhatak 2010 Clin O1 OGET 
1608 NHCC-50 Chhatak 2010 Clin O1 OGET 
1609 NHCC-51 Chhatak 2010 Clin O1 OGET 
1615 NHCC-57 Chhatak 2010 Clin O1 OGET 
1616 NHCC-58 Chhatak 2010 Clin O1 OGET 
1618 NHCC-60 Chhatak 2010 Clin O1 OGET 
1620 NHCC-62 Chhatak 2010 Clin O1 OGET 
1621 NHCC-63 Chhatak 2010 Clin O1 OGET 
1622 NHCC-64 Chhatak 2010 Clin O1 OGET 
1624 NHCC-66 Chhatak 2010 Clin O1 OGET 
1625 NHCC-67 Chhatak 2010 Clin O1 OGET 
1626 NHCC-68 Chhatak 2010 Clin O1 OGET 
1627 NHCC-69 Chhatak 2010 Clin O1 OGET 
1628 NHCC-70 Chhatak 2010 Clin O1 OGET 
1630 NHCC-72 Chhatak 2010 Clin O1 OGET 
1632 NHCC-74 Chhatak 2010 Clin O1 OGET 
1633 NHCC-75 Chhatak 2010 Clin O1 OGET 
1634 NHCC-76 Chhatak 2010 Clin O1 OGET 
1640 NHCC-82 Chhatak 2011 Clin O1 OGET 
1641 NHCC-83 Chhatak 2011 Clin O1 OGET 
1704 NHCC-088 Chhatak 2011 Clin O1 OGET 
1708 NHCC-092 Chhatak 2011 Clin O1 OGET 
1709 NHCC-093 Chhatak 2011 Clin O1 OGET 
1710 NHCC-094 Chhatak 2011 Clin O1 OGET 
1712 NHCC-096 Chhatak 2012 Clin O1 OGET 
1713 NHCC-097 Chhatak 2012 Clin O1 OGET 
1714 NHCC-098 Chhatak 2012 Clin O1 OGET 
1715 NHCC-099 Chhatak 2012 Clin O1 OGET 
1504 NHCM-002 Mathbaria 2011 Clin O1 OGET 
1505 NHCM-003 Mathbaria 2011 Clin O1 OGET 
1506 NHCM-004 Mathbaria 2011 Clin O1 OGET 
1507 NHCM-005 Mathbaria 2011 Clin O1 OGET 
1508 NHCM-006 Mathbaria 2011 Clin O1 OGET 
1509 NHCM-007 Mathbaria 2011 Clin O1 OGET 
1510 NHCM-008 Mathbaria 2011 Clin O1 OGET 
1511 NHCM-009 Mathbaria 2011 Clin O1 OGET 
1512 NHCM-010 Mathbaria 2011 Clin O1 OGET 
1513 NHCM-011 Mathbaria 2011 Clin O1 OGET 
1514 NHCM-012 Mathbaria 2011 Clin O1 OGET 
1515 NHCM-013 Mathbaria 2011 Clin O1 OGET 
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1516 NHCM-014 Mathbaria 2011 Clin O1 OGET 
1520 NHCM-017 Mathbaria 2011 Clin O1 OGET 
1521 NHCM-018 Mathbaria 2011 Clin O1 OGET 
1522 NHCM-019 Mathbaria 2011 Clin O1 OGET 
1523 NHCM-020 Mathbaria 2011 Clin O1 OGET 
1524 NHCM-021 Mathbaria 2011 Clin O1 OGET 
1525 NHCM-021A Mathbaria 2011 Clin O1 OGET 
1526 NHCM-022 Mathbaria 2011 Clin O1 OGET 
1527 NHCM-023 Mathbaria 2011 Clin O1 OGET 
1528 NHCM-024 Mathbaria 2011 Clin O1 OGET 
1529 NHCM-025 Mathbaria 2011 Clin O1 OGET 
1530 NHCM-026 Mathbaria 2011 Clin O1 OGET 
1531 NHCM-027 Mathbaria 2011 Clin O1 OGET 
1532 NHCM-028 Mathbaria 2011 Clin O1 OGET 
1533 NHCM-029 Mathbaria 2011 Clin O1 OGET 
1534 NHCM-030 Mathbaria 2011 Clin O1 OGET 
1535 NHCM-031 Mathbaria 2011 Clin O1 OGET 
1536 NHCM-032 Mathbaria 2011 Clin O1 OGET 
1537 NHCM-033 Mathbaria 2011 Clin O1 OGET 
1538 NHCM-034 Mathbaria 2011 Clin O1 OGET 
1539 NHCM-035 Mathbaria 2011 Clin O1 OGET 
1540 NHCM-036 Mathbaria 2011 Clin O1 OGET 
1541 NHCM-037 Mathbaria 2011 Clin O1 OGET 
1542 NHCM-038 Mathbaria 2011 Clin O1 OGET 
1543 NHCM-039 Mathbaria 2011 Clin O1 OGET 
1544 NHCM-040 Mathbaria 2011 Clin O1 OGET 
1545 NHCM-041 Mathbaria 2011 Clin O1 OGET 
1546 NHCM-042 Mathbaria 2011 Clin O1 OGET 
1547 NHCM-043 Mathbaria 2011 Clin O1 OGET 
1548 NHCM-044 Mathbaria 2011 Clin O1 OGET 
1549 NHCM-045 Mathbaria 2011 Clin O1 OGET 
1550 NHCM-046 Mathbaria 2011 Clin O1 OGET 
1551 NHCM-047 Mathbaria 2011 Clin O1 OGET 
1552 NHCM-048 Mathbaria 2011 Clin O1 OGET 
1553 NHCM-049 Mathbaria 2011 Clin O1 OGET 
1554 NHCM-050 Mathbaria 2011 Clin O1 OGET 
1555 NHCM-051 Mathbaria 2011 Clin O1 OGET 
1556 NHCM-052 Mathbaria 2011 Clin O1 OGET 
1557 NHCM-053 Mathbaria 2011 Clin O1 OGET 
1558 NHCM-054 Mathbaria 2011 Clin O1 OGET 
1823 NHCM-0055 Mathbaria 2011 Clin O1 OGET 
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1824 NHCM-0056 Mathbaria 2012 Clin O1 OGET 
1825 NHCM-0057 Mathbaria 2012 Clin O1 OGET 
1828 NHCM-0060 Mathbaria 2012 Clin O1 INET 
1829 NHCM-0061 Mathbaria 2012 Clin O1 INET 
1830 NHCM-0062 Mathbaria 2012 Clin O1 OGET 
1831 NHCM-0063 Mathbaria 2012 Clin O1 OGET 
1832 NHCM-0064 Mathbaria 2012 Clin O1 OGET 
1833 NHCM-0065 Mathbaria 2012 Clin O1 OGET 
1834 NHCM-0066 Mathbaria 2012 Clin O1 OGET 
1835 NHCM-0067 Mathbaria 2012 Clin O1 OGET 
1836 NHCM-0068 Mathbaria 2012 Clin O1 OGET 
1837 NHCM-0069 Mathbaria 2012 Clin O1 OGET 
1838 NHCM-0070 Mathbaria 2012 Clin O1 OGET 
1839 NHCM-0071 Mathbaria 2012 Clin O1 OGET 
1840 NHCM-0072 Mathbaria 2012 Clin O1 OGET 
1841 NHCM-0073 Mathbaria 2012 Clin O1 OGET 
1842 NHCM-0074 Mathbaria 2012 Clin O1 OGET 
1843 NHCM-0075 Mathbaria 2012 Clin O1 OGET 
1844 NHCM-0076 Mathbaria 2012 Clin O1 OGET 
1845 NHCM-0077 Mathbaria 2012 Clin O1 OGET 
1846 NHCM-0078 Mathbaria 2012 Clin O1 OGET 
1847 NHCM-0079 Mathbaria 2012 Clin O1 OGET 
1848 NHCM-0080 Mathbaria 2012 Clin O1 OGET 
1853 NHCM-0084 Mathbaria 2012 Clin O1 OGET 
1068 EC-0009 Chhatak 2010 Env O1 OGET 
1069 EC-0010 Chhatak 2010 Env O1 OGET 
1113 EC-0051 Chhatak 2011 Env O1 OGET 
1742 EC-0084 Chhatak 2011 Env O1 OGET 
1794 EC-0131 Chhatak 2012 Env O1 OGET 
1796 EC-0133 Chhatak 2012 Env O1 OGET 
1124 EM-1536 Mathbaria 2010 Env O1 OGET 
1126 EM-1537 Mathbaria 2010 Env O1 OGET 
1131 EM-1542 Mathbaria 2010 Env O1 OGET 
1132 EM-1543 Mathbaria 2010 Env O1 OGET 
1133 EM-1544 Mathbaria 2010 Env O1 OGET 
1134 EM-1545 Mathbaria 2010 Env O1 OGET 
1135 EM-1546 Mathbaria 2010 Env O1 OGET 
1136 EM-1547 Mathbaria 2010 Env O1 OGET 
1138 EM-1549 Mathbaria 2010 Env O1 OGET 
1139 EM-1550 Mathbaria 2010 Env O1 OGET 
1153 EM-1561 Mathbaria 2011 Env O139   
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1233 EM-1626 Mathbaria 2011 Env O1 OGET 
1264 EM-1648B Mathbaria 2011 Env O1 OGET 
1269 EM-1652 Mathbaria 2011 Env O1 OGET 
1270 EM-1652A Mathbaria 2011 Env O1 OGET 
1271 EM-1653 Mathbaria 2011 Env O1 OGET 
1272 EM-1653A Mathbaria 2011 Env O1 OGET 
1280 EM-1658A Mathbaria 2011 Env O1 OGET 
1283 EM-1659B Mathbaria 2011 Env O1 OGET 
1311 EM-1676A Mathbaria 2011 Env O1 OGET 
1314 EM-1678 Mathbaria 2011 Env O1 OGET 
1316 EM-1678B Mathbaria 2011 Env O1 OGET 
1332 EM-1688A Mathbaria 2011 Env O1 OGET 
1335 EM-1690 Mathbaria 2011 Env O1 OGET 
1336 EM-1690A Mathbaria 2011 Env O1 OGET 
1362 EM-1706 Mathbaria 2011 Env O1 OGET 
1363 EM-1706A Mathbaria 2011 Env O1 OGET 
1402 EM-1727 Mathbaria 2011 Env O1 OGET 
1888 EM-1831 Mathbaria 2011 Env O1 OGET 
1892 EM-1834 Mathbaria 2011 Env O1 OGET 
1894 EM-1835 Mathbaria 2011 Env O1 OGET 
1898 EM-1838 Mathbaria 2011 Env O1 OGET 
1900 EM-1839 Mathbaria 2011 Env O1 OGET 
1901 EM-1839A Mathbaria 2011 Env O1 OGET 
1902 EM-1840 Mathbaria 2011 Env O1 OGET 
1903 EM-1840A Mathbaria 2011 Env O1 OGET 
2026 EM-1958 Mathbaria 2012 Env O1 INET 
2028 EM-1958B Mathbaria 2012 Env O1 INET 
2036 EM-1964 Mathbaria 2012 Env O1 INET 
2038 EM-1964B Mathbaria 2012 Env O1 INET 
2050 EM-1972A Mathbaria 2012 Env O1 OGET 
2051 EM-1973 Mathbaria 2012 Env O1 OGET 
2052 EM-1973A Mathbaria 2012 Env O1 OGET 
2053 EM-1974 Mathbaria 2012 Env O1 OGET 
2060 EM-1979 Mathbaria 2012 Env O1 OGET 
2061 EM-1979A Mathbaria 2012 Env O1 OGET 
2062 EM-1980 Mathbaria 2012 Env O1 OGET 
2071 EM-1984 Mathbaria 2012 Env O1 OGET 
2073 EM-1984B Mathbaria 2012 Env O1 OGET 
2104 EM-2008 Mathbaria 2012 Env O1 OGET 
2129 EM-2026E Mathbaria 2012 Env O1 OGET 
2136 EM-2030 Mathbaria 2012 Env O1 OGET 
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2138 EM-2030B Mathbaria 2012 Env O1 OGET 
2142 EM-2033 Mathbaria 2012 Env O1 OGET 
2144 EM-2033B Mathbaria 2012 Env O1 OGET 
2149 EM-2037 Mathbaria 2012 Env O1 OGET 
2151 EM-2037B Mathbaria 2012 Env O1 OGET 
*OGET  Ogawa El Tor 
*INET  Inaba El Tor 
 
 
2.2 Disc diffusion for Antibiogram 
Disc diffusion method was employed to investigate the antibiotic susceptibility of the V. 
cholerae strains to penicillins, monobactems, carbapenems, and third and fourth generation 
cephalosporins. To perform the disc diffusion method strains stored in glycerol were spread on 
LB plated. One or two colonies were picked and resuspended in 2 mL of sterile saline to make a 
homogenous solution (used McFarland standard to obtain a 0.5 McFarland turbidity). Then 
sterile swabs were used to inoculate Muller Hilton plates (MH agar is considered the best 
medium to use for routine susceptibility testing of non-fastidious bacteria and antibiotic discs) 
and antibiotic discs were immediately place on these plates while employing sterile techniques. 
A list of the Antibiotics used in this experiment and the zone diameter interpretive standards set 
by Clinical and Laboratory Standards Institute can be found in the following Table 8.  
Table 8. Zone Diameter Interpretive Standards 
Antibiotic 
name 
 Resistant Intermediate Sensitive 
Ampicillin AM-10 ≤13 14-16 ≥17 
Penicillin P-10 ≤13 14-16 ≥17 
Cefotaxime CTX-30 ≤22 23-25 ≥26 
Ceftazidime CAZ-30 ≤17 18-20 ≥21 
Ceftriaxone CRO-30 ≤22 23-25 ≥26 
Cefoxitin FOX-30 ≤14 15-17 ≥18 
Cefepim FEP-30 ≤14 15-17 ≥18 
Imipenem IPM-10 ≤13 14-15 ≥16 
Aztreonam ATM-30 ≤17 18-20 ≥21 
Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; seventeenth informational 
supplement. CLSI document M100-S17, Wayne, Pennsylvania, USA [56]. 
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The plates were then incubated over night at 35°C. The diameters of cleared zone around 
the antibiotic discs were measured and the susceptibility profile of each strain was determined 
according to Table 8. Figure 5 and 6 below demonstrate results from disc diffusion test on strains 





Figure 5. Using disc 
diffusion method to analyze 
strain 1134 for susceptibility 
against Aztreonam (ATM), 
Ceftriaxone (CRO), 
Penicillin (P), Cefotaxime 
(CTX), and Ampicillin 
(AM). Red circles indicate 
the location of the antibiotic 
discs.  
A corresponds to ATM 
antibiotic disc with a 
clearance zone diameter of 
23mm indicating that the 
strain is sensitive to ATM. 
B corresponds to CRO 
antibiotic disc with a 
clearance zone diameter of 
27mm indicating that the 
strain is sensitive to CRO. 
C corresponds to P 
antibiotic disc with clearance 
zone diameter of 9mm 
indicating that the strain is 
resistant to P. 
D corresponds to CTX 
antibiotic disc with a 
clearance zone diameter of 
29mm indicating that the 
strain is sensitive to CTX. 
E  corresponds to AM 
antibiotic disc with a 
clearance diameter of 10 mm 
indicating that the strain is 











2.3 DNA Extraction and PCR 
Alongside the antibiotic susceptibility experiments DNA extraction from the same strains 
was performed by using boiling methods. This technique is simple, reproducible, can be 
performed rapidly, and is effective against clinical samples. For this method 1-2 colonies from 
LB plate containing each strain were resuspended into 100 µl nuclease free water. This mixture 
was then boiled for 15 minutes at 99°C and then centrifuged for 10 minutes at 15000 rpm. The 
supernatant was then collected and stored at -20°C for genotypic analysis of the strains. 
In order to further analyze the resistant strains and the source of the observed resistance, 
single PCR analysis using primers targeted for each of blaCTX, blaSHV, blaTEM, blaIMP, 
A 
Figure 6. Using disc 
diffusion method to 





Red circles indicate 
the location of the 
antibiotic discs.  
A corresponds to 
ATM antibiotic disc 
with a clearance zone 
diameter of 23mm 
indicating that the 
strain is sensitive to 
ATM. 
B corresponds to 
CRO antibiotic disc 
with a clearance zone 
diameter of 26mm 
indicating that the 






blaSPM, blaVIM, blaBIC, blaNDM, blaKPC, blaAIM, blaDIM, blaSIM, and blaGIM genes 
was carried out. Table 9 lists all the primers used in this study, their sequence, gene target, 




Table 9. List of Primers used  
FAMILY Primer Sequence 
Gene 









MU1 ATGTGCAGYACCAGTAARGT blaCTX 544 
Jemima 2008 









ATG CGT TAT WTT CGC CTG 











GTA TCC GCT CAT GAG ACA 




TCT AAA GTA TAT ATG AGT 















































































 A single reaction mixture containing 1 µL of DNA extract, 12.5 µL of Promega GoTaq 
Green Master Mix, 1 µL of each forward and reverse primers, and 9.5µL of nuclease free water 
were used in a total volume of 25 µL. Amplification was carried out with the following thermal 
cycling conditions (with all the primers except TEM-F1 & R1, SHV-F1 & R1, CTXM-F1& R1): 
10 minutes at 94°C and 36 cycles of amplification consisting of 30 seconds at 94°C, 40 seconds 
at the specific annealing temperature of each primer, and 50 seconds at 72°C, with 5 minutes at 
72°C for the final extension. The specific annealing temperatures used are listed in Table 10. 
Table 10. Specific Annealing Temperatures used for each Primer 
Primer Annealing Temperature Used 
CTX 52 












The program used for CTXM-F1& R1 primers was the following: 3 minutes at 94°C and 25 
cycles of amplification consisting of 30 seconds at 94°C, 1 minute at 54°C, and 2 minutes at 
72°C, with 7 minutes at 72°C for the final extension. The program used with TEM-F1 & R1 
primers was 3 minutes at 95°C and 30 cycles of amplification consisting of 1 minute at 95°C, 1 
minute at 55°C, and 1 minute at 72°C, with 5 minutes at 72°C for the final extension. For 
amplification of SHV gene where SHV-F1 & R1 primers were used the thermal cycler program 
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employed was 3 minutes at 95°C and 30 cycles of amplification consisting of 15 seconds at 
94°C, 30 seconds at 60°C, and 1 minute at 72°C, with 5 minutes at 72°C for the final extension. 
Following PCR amplification, DNA fragments were analyzed by gel electrophoresis in a 
2.5% agarose gel at 100 V for 1 hour and 15 minutes in 1X Tris-acetate-EDTA (TAE). The gel 





3. Results and Discussions 
3.1 Antibiogram 
To investigate the antibiotic resistance profile of environmental and clinical V. cholerae 
O1 strains isolated from two different sites in Bangladesh (Chhatak and Mathbaria) during 
2009 to 2012, a total of 210 strains were studied using the disc diffusion method. From these 
strains, 69 were resistant to at least penicillin, ceftriaxone or cefotaxime. Combinations of 
these resistances with ampicillin, cefoxitin, ceftazidime, imipenem and/or aztreonam were 
detected in both clinical and environmental strains from both provinces (Table 11).  
Differences in resistance profile of strains collected from Mathbaria and Chhatak is 
observed. Out of the 74 strains collected from Mathbaria 27.6% were resistant to penicillin, 
5.2% were resistant to cefotaxime, 11.9% were resistant to ceftriaxone, 2.2% resistant to 
cefoxitin, and 3.0% were resistant to azteronam. Strains collected from the Chhatak province 
mainly demonstrate higher resistance to cefotaxime, ceftriaxone, and cefoxitin; 23.0% 
resistant to penicillin, 14.9% resistant to cefotaxime, 29.7% resistant ceftriaxone, and 4.1% 
resistant to cefoxitin. Figure 7 is a histogram representing the resistance profile of strains 
collected from the two provinces for each of the antibiotics tested. These differences highlight 
the importance of geographical location on the phenotypic fate of bacterial strains. Comparing 
the clinical and environmental strains collected from both of the locations it observed that 
clinical samples demonstrate resistance to multiple antibiotics compared to environmental 
strains. Differences in resistance profile of clinical and environmental samples are expected 







































Figure 7. V. cholerae strains response to β-lactams from samples collected in the province 
of Mathbaria (above Histogram) and Chhatak (below histogram). AM, ampicillin; P, 
penicillin, CTX, cefotaxime; CAZ, ceftazidime; CRO, ceftriaxone; FOX, cefoxitin; FEP, 







Table 11. List of 69 strains that confer resistance to the antibiotics studied 
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3.2 PCR results 
Genotypic analysis of the 69 strains that showed phenotypic resistance was carried out by 
multiplex and uniplex PCR amplification on 13 different beta-lactamase genes, using primers 
listed in Table 9.  
Multiplex PCR can be used to screen a great number of clinical isolates producing ESBL 
and metallo β-lactamases. [57] and [58] had employed this method for studying 
carbapenemase genes and ESBL producing blaSHV and blaCTX-M genes and were able to 
gather satisfactory results with no unspecific amplicons. However, when the multiplex PCR 
approach was used in this study a lack of specificity was observed.  
A uniplex method was then employed to gain the ability to distinguish the different amplicons 
corresponding to the various genes being studied. None of the resistant genes were detected in 












Figure 8 (on the left). Agarose gel 
electrophoresis (2.5%) used for detection of 
blaSPM. The size of the amplicon for this 
gene is 271 bp. There are two ladders used 
here are 2 kb Bioline HyperladderII and 
1.013 kb Hyperladder IV. There are a lot of 
unspecific amplicons and no amplicons 
indicating the presence of blaSPM. The 
negative control that was used in amplifying 





Figure 9 (on the left). Agarose gel 
electrophoresis (2.5%) used for detection of 
blaTEM. The size of the amplicon for this 
gene is 840 bp. There are two ladders used 
here are 2 kb Bioline HyperladderII and 
1.013 kb Hyperladder IV. There are a lot of 
unspecific amplicons and no amplicons 
indicating the presence of blaTEM. The 
negative controlled used in this experiment in 
V. cholerae MO10 and the positive control is 









Preliminary data on the complete sequencing of strains NHCC-04, NHCC-06, NHCC-08, 
and EM-1727 showed that they do not contain any of the 13 β-lactamase genes investigated in 
this project. This finding reinforces the idea that the amplicons observed in all the PCRs are the 
result of non-specific amplification. However, these four strains all encode five putative proteins 
holding domains belonging to the metallo-beta-lactamase superfamily or motifs involved in 
RNA-metabolising metallo-beta-lactamase. Further investigation is required to understand the 






Beta-lactamases are resistance determinants of increasing clinical relevance in Gram-
negative bacteria. Because of their broad range, these enzymes can confer resistance to almost all 
beta-lactams in pathogenic bacteria. Vibrio cholerae is both an autochthonous inhabitant of 
riverine and estuarine environments and a human facultative pathogen. Being the etiological 
agent of cholera, V. cholerae is a major public health problem in several developing countries.  
This study demonstrated the presence of intermediate resistance to ampicillin, 2nd-, and 
3rd-generation cephalosporins among the strains isolated both from clinical and environmental 
samples. All strains were sensitive to the 4th–generation beta-lactam cefepime. This is the first 
report documenting such extensive resistance to monobactams and third-generation 
cephalosporin in V. cholerae. Further analysis of resistance determinants is required to establish 
the correlation between phenotype resistance and genetic determinants in order to determine the 
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